A Pilot Randomised Controlled Trial of a Nurse-led Survivorship Intervention for Empowering Patients with Hodgkin's and Non-Hodgkin's Lymphoma after treatment: (The Engage Trial-Pilot)
Not Applicable
Not yet recruiting
- Conditions
- Non-Hodgkin's LymphomaHodgkin's Lymphoma
- Registration Number
- ACTRN12617000068369
- Lead Sponsor
- Prof Raymond Chan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie nurse-led survivorship interventions in lymphoma patients post-treatment?
How does the Engage Trial-Pilot compare to standard-of-care in managing long-term outcomes for Hodgkin's and Non-Hodgkin's Lymphoma survivors?
Are there specific biomarkers associated with improved patient empowerment outcomes in lymphoma survivorship programs?
What adverse events are commonly reported in nurse-led post-treatment interventions for hematological malignancies?
What combination therapies or pharmaceutical strategies are being explored alongside survivorship care for lymphoma patients?